The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
LONDON, UK and NEW YORK, January 24, 2008 – GlaxoSmithKline (GSK) and the Global Alliance for TB Drug Development (TB
NEW YORK & CAPE TOWN, South Africa–The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery and development of
New York – The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership accelerating the discovery
Beijing and New York, January 31, 2007 – The Institute of Materia Medica (IMM), a member of the Chinese Academy
TB Alliance Board of Directors Appoints Three New Members New Stakeholders Association President Joins Board as Member Ex Officio For
PARIS (Nov. 2, 2006) – Responding to a tuberculosis (TB) pandemic that is growing more threatening and deadly, the Dutch
NEW YORK (Oct. 12, 2006) – The Global Alliance for TB Drug Development (TB Alliance) announced today that it has
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
